Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PSYENCE GROUP INC.
No Price
30.04.2026 20:00
Current Prices from PSYENCE GROUP INC.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
PSYGF
USD
30.04.2026 20:00
0,13 USD
0,00 USD
Share Float & Liquidity
Free Float96,41 %
Shares Float15,08 M
Shares Outstanding15,64 M
Company Profile for PSYENCE GROUP INC. Share
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.
